DXCM - Ready to Buy the Dip? This Healthcare Stock Is a Smart Buy
This bear market may not exactly put you in the mood for investing. But now is actually a great time to scoop up shares of solid companies. Why? Because many are trading at a discount. Yet their long-term outlooks remain bright.
This is the case for DexCom (NASDAQ: DXCM) . The company specializes in continuous glucose monitoring (CGM) systems. The business is doing well today -- and is set to keep on growing. At the same time, DexCom shares have dropped 25% this year. So, if you're ready to buy the dip, this stock is one to consider. Let's take a closer look at why you may want to add DexCom to your portfolio.
DexCom sells the G6, G7, and DexCom One CGM systems to diabetes patients so they can keep track of their blood sugar levels. These systems are efficient because a sensor implanted just under the skin monitors levels on a continual basis. And they're easy for users because, unlike finger-stick testing, they don't involve pricking a person's finger with a needle.
For further details see:
Ready to Buy the Dip? This Healthcare Stock Is a Smart Buy